Patient activation in advanced chronic kidney disease: a cross-sectional study

被引:2
|
作者
Lunardi, Laura E. [1 ,2 ]
Le Leu, Richard K. [1 ,3 ]
Matricciani, Lisa A. [2 ]
Xu, Qunyan [2 ]
Britton, Anne [1 ]
Jesudason, Shilpanjali [1 ]
Bennett, Paul N. [4 ]
机构
[1] Cent Northern Adelaide Renal & Transplantat Serv, Adelaide, SA, Australia
[2] Univ South Australia, Clin & Hlth Sci, Adelaide, SA, Australia
[3] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia
[4] Griffith Univ, Sch Nursing & Midwifery, Southport, Qld, Australia
关键词
Chronic kidney disease; Self-management; Patient activation; Medication adherence; SELF-MANAGEMENT;
D O I
10.1007/s40620-023-01847-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Patient activation refers to the knowledge, confidence and skills required for the management of chronic disease and is antecedent to self-management. Greater self-management in chronic kidney disease (CKD) results in improved patient experience and patient outcomes. Aim To examine patient activation levels in people with CKD stage 5 pre-dialysis and determine associations with sociodemographic characteristics, treatment adherence and healthcare utilisation. Methods/design People with CKD stage 5 not receiving dialysis from one Australian kidney care service. Patient activation was measured using the 13-item Patient Activation Measure (PAM-13). Sociodemographic and clinical outcome data (emergency department visits, admissions) were collected from medical records. Morisky Medication Adherence Scale was used to determine self-report medication adherence. Results Two hundred and four participants completed the study. The mean PAM-13 score was 53.4 (SD 13.8), with 73% reporting low activation levels (1 and 2). Patient activation scores significantly decreased with increased age (P < 0.001) and significantly increased with higher educational levels (P < 0.001). Higher patient activation level was associated with fewer hospital emergency department visits (P = 0.03) and increased medication adherence (P < 0.001). Conclusion Patient activation levels are low in people with CKD stage 5 not receiving dialysis suggesting limited ability for self-management and capacity for optimally informed decisions about their healthcare. Efforts to improve patient activation need to consider age and education level.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [1] Patient activation in advanced chronic kidney disease: a cross-sectional study
    Laura E. Lunardi
    Richard K. Le Leu
    Lisa A. Matricciani
    Qunyan Xu
    Anne Britton
    Shilpanjali Jesudason
    Paul N. Bennett
    [J]. Journal of Nephrology, 2024, 37 : 343 - 352
  • [2] Determinants of patient activation and its association with cardiovascular disease risk in chronic kidney disease: A cross-sectional study
    Wilkinson, Thomas J.
    Memory, Katherine
    Lightfoot, Courtney J.
    Palmer, Jared
    Smith, Alice C.
    [J]. HEALTH EXPECTATIONS, 2021, 24 (03) : 843 - 852
  • [3] Exploring patient delay in people with chronic kidney disease: A cross-sectional study
    Zheng, Jie
    Guo, Ao-Han
    Xue, Bo-Wen
    Wu, Shu-Yan
    Wang, Xi-Xiang
    Jing, Yue-Juan
    Zhai, Lin-Jun
    Liu, Rong
    [J]. MEDICINE, 2024, 103 (07) : E37077
  • [4] PATIENT ACTIVATION IN PEOPLE WITH CHRONIC KIDNEY DISEASE NOT RECEIVING KIDNEY REPLACEMENT THERAPY: A CROSS-SECTIONAL SURVEY
    Lunardi, Laura
    Le Leu, Richard
    Britton, Anne
    Xu, Qunyan
    Matricciani, Lisa
    Jesudason, Shilpa
    Bennett, Paul
    [J]. NEPHROLOGY, 2023, 28 : 47 - 47
  • [5] Advanced chronic kidney disease in kidney transplant recipients: A national cross-sectional cohort study
    Medved, Bojan
    Ponikvar, Jadranka Buturovic
    Arnol, Miha
    Gubensek, Jakob
    [J]. TRANSPLANTATION, 2024, 108 (09) : 565 - 565
  • [6] Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study
    Zimbudzi, Edward
    Lo, Clement
    Ranasinha, Sanjeeva
    Fulcher, Gregory R.
    Jan, Stephen
    Kerr, Peter G.
    Polkinghorne, Kevan R.
    Russell, Grant
    Walker, Rowan G.
    Zoungas, Sophia
    [J]. BMJ OPEN, 2017, 7 (10):
  • [7] Hemoglobin Variability in Chronic Kidney Disease: A Cross-Sectional Study
    Spiegel, David M.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (05): : 340 - 343
  • [8] Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study
    Bolignano, Davide
    Greco, Marta
    D'Agostino, Mario
    Cianfrone, Paola
    Tripodi, Loredana
    Misiti, Roberta
    Zicarelli, Mariateresa
    Ganino, Ludovica
    Foti, Daniela Patrizia
    Andreucci, Michele
    Coppolino, Giuseppe
    [J]. MEDICINA-LITHUANIA, 2023, 59 (08):
  • [9] Chronic kidney disease in sugarcane workers in Cameroon: a cross-sectional study
    Ekiti, Martin E.
    Zambo, Jean-Berthelot
    Assah, Felix K.
    Agbor, Valirie N.
    Kekay, Krystel
    Ashuntantang, Gloria
    [J]. BMC NEPHROLOGY, 2018, 19
  • [10] THE RELATION BETWEEN OBESITY AND CHRONIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY
    Timar, Romulus
    Chita, Teodora
    Timar, Bogdan
    Vlad, Mihaela
    Degeratu, Diana
    Mazilu, Octavian
    [J]. INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE, 2015, : 316 - 322